Symptom burden in cancer survivorship

Journal of Cancer Survivorship

Volumn 1, Issue 2, 2007, Pages 167-175

  Burkett, V Shannon ^a   Cleeland, Charles S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer survivor; Quality of life; Symptom burden; Symptoms

Indexed keywords

ARTICLE; COST OF ILLNESS; HEALTH STATUS; HUMAN; NEOPLASM; OUTCOME ASSESSMENT; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SURVIVOR;

COST OF ILLNESS; HEALTH STATUS; HUMANS; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SURVIVORS;

EID: 34250174193     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-007-0017-y     Document Type: Article

References (66)

1. Alfano, C. M., McGregor, B. A., Kuniyuki, A., Reeve, B. B., Bowen, D. J., Baumgartner, K. B., et al. (2006). Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors. Psychooncology, 15(11), 985-1000.
2. Antoni, M. H., Lehman, J. M., Kilboum, K. M., Boyers, A. E., Culver, J. L., Alferi, S. M., et al. (2001). Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychology, 20(1), 20-32.
3. Ashing-Giwa, K. T. (2005). The contextual model of HRQoL: A paradigm for expanding the HRQoL framework. Quality of Life Research, 14(2), 297-307.
4. Aziz, N. M. (2002). Cancer survivorship research: Challenge and opportunity. Journal of Nutrition, 712(11 Suppl), 3494S-3503S.
5. Bailey, R. K., Geyen, D. J., Scott-Gurnell, K., Hipolito, M. M., Bailey, T. A., & Beal, J. M. (2005). Understanding and treating depression among cancer patients. International Journal of Gynecological Cancer, 15(2), 203-208.
6. Barsevick, A. M., Whitmer, K., Nail, L. M., Beck, S. L., & Dudley, W. N. (2006). Symptom cluster research: Conceptual, design, measurement, and analysis issues. Journal of Pain and Symptom Management, 31(1), 85-95.
7. Bender, C. M., Ergyn, F. S., Rosenzweig, M. Q., Cohen, S. M., & Sereika, S. M. (2005). Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nursing, 28(3), 219-225.
8. Borgaonkar, M. R., & Irvine, E. J. (2000). Quality of life measurement in gastrointestinal and liver disorders, Gut, 47(3), 444-454.
9. Bottomley, A., Flechtner, H., Efficace, F., Vanvoorden, V., Coens, C., Therasse, P., et al. (2005). Health related quality of life outcomes in cancer clinical trials. European Journal of Cancer, 41 (12), 1697-1709.
10. Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. Journal of Palliative Care, 7(2), 6-9.
11. Buchanan, D. R., O'Mara, A. M., Kelaghan, J. W., & Minasian, L. M. (2005). Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program. Journal of Clinical Oncology, 23(3), 591-598.
12. Bush, N. E., Haberman, M., Donaldson, G., & Sullivan, K. M. (1995), Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Social Science & Medicine, 40(4), 479-490.
13. Cella, D., Davis, K., Breitbart, W., & Curt, G. (2001). Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors, Journal of Clinical Oncology, 19(14), 3385-3391.
14. Chang, V. T., Hwang, S. S., Kasimis, B., & Thaler, H. T. (2004). Shorter symptom assessment instruments: The Condensed MeSymptom Assessment Scale (CMSAS). Cancer Invest, 22 (4), 526-536.
15. Cleeland, C. S. (2001). Cancer-related fatigue: New directions for research. Introduction. Cancer, 92(6 Suppl), 1657-1661.
16. Cleeland, C. S. (2007). Symptom burden: Multiple symptoms and their impact as patient-reported outcomes. Journal of the National Cancer Institute, (in press).
17. Cleeland, C. S.,Bennett, G. J., Dantzer, R., Dougherty, P. M., Dunn, A. J., Meyers, C. A., et al. (2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer, 97(11), 2919-2925.
18. Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., et al. (2000). Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer, 89(1), 1634-1646.
19. Cleeland C. S., & Reyes-Gibby, C. C. (2002). When is it justified to treat symptoms? Measuring symptom burden. Oncology (Williston.Park), 16(9 Suppl 10), 64-70.
20. De Boer, A. G., Genovesi, P. I., Sprangers, M. A., Van Sandick, J. W., Obertop, H., & Van Lanschot, J. J. (2000). Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. British Journal of Surgery, 57(12), 1716-1721.
21. De Haes, J. C. (1988). Quality of life: Conceptual and theoretical considerations. In M. Watson, S. Greer, & C. Thomas (Eds.), Psychosocial oncology (pp. 61-70). Oxford: Pergamon.
22. De Haes, J. C., Van Knippenberg, F. C., & Neijt, J. P. (1990). Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. British Journal of Cancer, 62(6), 1034-1038.
23. Dodd, M. J., Miaskowski, C., & Paul, S. M. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28(3), 465-470.
24. Donnelly, S., Walsh, D., & Rybicki, L. (1995). The symptoms of advanced cancer: Identification of clinical and research priorities by assessment of prevalence and severity. Journal Of Palliative Care, 11(1), 27-32.
25. Fallowfield, L., Cella, D., Cuzick, J., Francis, S., Locker, G., & Howell, A. (2004). Quality of life of postmenopausal women in the Arimidex, Tamoxifen, alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. Journal of Clinical Oncology, 22 (21), 4261-4271.
26. Fossa, S. D., Dahl, A. A., & Haaland, C. F. (1999). Health-related quality of life in patients treated for testicular cancer. British Journal of Cancer, 9(5), 425-429.
27. Ganz, P. A. (2001). Late effects of cancer and its treatment. Seminars in Oncology Nursing, 17(4), 241-248.
28. Ganz, P. A. (2006). Monitoring the physical health of cancer survivors: A survivorship-focused medical history. Journal of Clinical Oncology, 24(32), 5105-5111.
29. Ganz, P. A., Coscarelli, A., Fred, C., Kahn, B., Polinsky, M. L., & Petersen, L. (1996). Breast cancer survivors: Psychosocial concerns and quality of life. Breast Cancer Research and Treatment, 38(2), 183-199.
30. Ganz, P. A., Kwan, L., Stanton, A. L., Krupnick, J. L., Rowland, J. H., Meyerowitz, B. E., et al. (2004). Quality of life at the end of primary treatment of breast cancer: First results from the moving beyond cancer randomized trial. Journal of the National Cancer Institute, 96(5), 376-387.
31. Ganz, P. A., Rowland, J. H., Meyerowitz, B. E., & Desmond, K. A. (1998). Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results in Cancer Research, 152, 396-411.
32. Gaston-Johansson, F., Fall-Dickson, J. M., Bakos, A. B., & Kennedy, M. J. (1999). Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Practice, 7(5), 240-247.
33. Grond, S., Zech, D., Diefenbach, C., & Bischoff, A. (1994). Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. Journal of Pain and Symptom Management, 9(6), 372-382.
34. Grothey, A. (2005). Clinical management of oxaliplatin-associated neurotoxicity, Clinical Colorectal Cancer, 5 Suppl 1, S38-S46.
35. Gutstein, H. B. (2001). The biologic basis of fatigue, Cancer, 92(6 Suppl), 1678-1683.
36. Hammerlid, E., Silander, E., Homestam, L., & Sullivan, M. (2001). Health-related quality of life three years after diagnosis of head and neck cancer-a longitudinal study. Head and Neck, 23(2), 113-125.
37. Hammerlid, E., & Taft, C. (2001). Health-related quality of life in long-term head and neck cancer survivors: A comparison with general population norms, British Journal of Cancer, 84(2), 149-156.
38. Hart, B. L. (1988). Biological basis of the behavior of sick animals. Neumncience and Biobehavioral Reviews, 12(2), 123-137.
39. Hewitt, M. E., Greenfield, S., Stovall, E. (Eds.) (2005). From cancer patient to cancer survivor: Lost in transition. Washington, DC: National Academies Press.
40. Huguenin, P. U., Taussky, D., Moe, K., Meister, A., Baumen, B., Lutolf, U. M., et al. (1999). Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: The importance of the target volume. International Journal of Radiation Oncology, Biology, Physics, 45(1), 47-52.
41. Kelley, K. W., Bluthe, R. M., Dantzer, R., Zhou, J. H., Shen, W. H., Johnson, R. W., et al. (2003). Cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 17 Suppl 1, S112-S118.
42. Kent, S., Bluthe, R. M., Kelley, K. W., & Dantzer, R. (1992). Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences, 13(1), 24-28.
43. Kim, H. J., McGuire, D. B., Tulman, L., & Barsevick, A. M. (2005). Symptom clusters: Concept analysis and clinical implications for cancer nursing. Cancer Nursing, 28(4), 270-282.
44. Kirkova, J., Davis, M. P., Walsh, D., Tieman, E., O'Leary, N., LeGrand, S. B., et al. (2006), Cancer symptom assessment instruments: A systematic review. Journal of Clinical Oncology, 24(9), 1459-1473.
45. Klinkenberg, M., Willems, D. L., van der, W. G., & Deeg, D. J. (2004). Symptom burden in the last week of life. Journal of Pain and Symptom Management, 27(1), 5-13.
46. Kurzrock, R. (2001). The role of cytokines in cancer-related fatigue, Cancer, 92(6 Suppl), 1684-1688.
47. Lee, B. N., Dantzer, R., Langley, K. E., Bennett, G. J., Dougherty, P. M., Dunn, A. J., et al. (2004). A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation, 11(5), 279-292.
48. Miaskowski, C., Dodd, M., & Lee, K. (2004). Symptom clusters: the new frontier in symptom management research. Journal of the National Cancer Institute. Monographs, 32, 17-21.
49. Miaskowski, C., & Lee, K. A. (1999). Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: A pilot study. Journal of Pain and Symptom Management, 17(5), 320-332.
50. Mols, F., Vingerhoets, A. J., Coebergh, J. W., & van de Poll-Franse L. V. (2005). Quality of life among long-term breast cancer survivors: A systematic review. European Journal of Cancer, 41 (17), 2613-2619.
51. Paice, J. A. (2004). Assessment of symptom clusters in people with cancer, Journal of the National Cancer Institute. Monographs, 32, 98-102.
52. Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendricks, C. B., Levin, B., et al. (2004). National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: Pain, depression, and fatigue, July 15-17, 2002. Journal of the National Cancer Institute. Monographs, 32, 9-16.
53. Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Kiyasu, E., et al. (1994). The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer, 30A(9), 1326-1336.
54. Rauch, P., Miny, J., Conroy, T., Neyton, L., & Guillemin, F. (2004), Quality of life among disease-free survivors of rectal cancer. Journal of Clinical Oncology, 22(2), 354-360.
55. Reyes-Gibby, C. C., Aday, L. A., Anderson, K. O., Mendoza, T. R., & Cleeland, C. S. (2006). Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. Journal of Pain and Symptom Management, 32(2), 118-128.
56. Ross, J. R., Goller, K.., Hardy, J., Riley, J., Broadley, K., A'hern, R., et al. (2005). Gabapentin is effective in the treatment of cancer-related neuropathic pain: A prospective, open-label study, Journal of Palliative Medicine, 8(6), 1118-1126.
57. Rudberg,' L., Carlsson, M., Nilsson, S., & Wikblad, K. (2002). Self-perceived physical, psychologic, and general symptoms in survivors of testicular cancer 3 to 13 years after treatment. Cancer Nursing, 25(3), 187-195.
58. Schwartz, C. E., & Sprangers, M. A. (1999). Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research, Social Science & Medicine, 48 (11), 1531-1548.
59. Silveira, M. J., Kabeto, M. U., & Langa, K. M. (2005). Net worth predicts symptom burden at the end of life. Journal of Palliative Medicine, 5(4), 827-837.
60. Sprangers, M. A. G., & Schwartz, C. E. (1999), Integrating response shift into health-related quality of life research: A theoretical model. Social Science & Medicine, 45(11), 1507-1515.
61. Steineck, G., Bergmark, K., Henningsohn, L., al-Abany, M., Dickman, P. W., & Helgason, A. (2002), Symptom documentation in cancer survivors as a basis for therapy modifications. Acta Oncologica, 41(3), 244-252.
62. Valentine, A. D., & Meyers, C. A. (2001). Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer, 92(6 Suppl), 1694-1698.
63. Van Weert, E., Hoekstra-Weebers, J., Grol, B., Otter, R., Arendzen, H. J., Postema, K., et al. (2005). A multidimensional cancer rehabilitation program for cancer survivors: Effectiveness on health-related quality of life. Journal of Psychosomatic Research, 58(6), 485-496.
64. Wang, X. S., Fairclough, D. L., Liao, Z., Komaki, R., Chang, J. Y., Mobley, G. M., et al. (2006). Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. Journal of Clinical Oncology, 24(27), 4485-4491.
65. Webster's Third New International Dictionary of the English Language, U. (1966). (15th ed.) Springfield, MA: Merriam.
66. Zambroski, C. H., Moser, D. K., Bhat, G., & Ziegler, C. (2005). Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. European Journal of Cardiovascular Nursing, 4(3), 198-206.